1. Health Strategies Group
Key Finding #1
2/28/2019
Health Strategies Group
C-Suite Executives Identify the Majority of Biopharmaceutical Relationships as Transactional or Collaborative
Out of 1,950 potential relationships with biopharmaceutical companies, c-suite executives classify 24% as Transactional and 26% as Collaborative
Sixty-eight percent (68%) of c-suite executives indicate an organizational relationship between their organization and the biopharmaceutical industry
Forty-three percent (43%) of respondents report a Collaborative or Partner relationship with biopharmaceutical companies
Slight year-to-year variations in the relationship distribution result from adding biopharmaceutical companies to the study and changes to the research panel; however the proportion of Stressed, Transactional, Collaborative, and Partner relationships remains consistent with past years
Request slides